FactSet Schedules First Quarter 2020 Earnings Call
NORWALK, Conn., Nov. 21, 2019 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS | NASDAQ: FDS), a global provider of integrated financial information, analytical applications, and industry-leading services, today announced that it will release its financial and operating results for the first quarter fiscal 2020, ending November 30, on Thursday, December 19, 2019. FactSet will also host a conference call to discuss these results at 11:00 a.m. eastern time.
The following information is provided for investors who would like to participate in the conference call and webcast:
| U.S. Participants | 833.231.8259 | |
| International Participants | 647.689.4104 | |
| Passcode | 4776222 | |
| Webcast | FactSet Investor Relations |
An archived webcast with the accompanying slides will be available at investor.factset.com for one year after the conclusion of the live event. The earnings call transcript will also be available via FactSet’s transcription service. An audio replay of this conference will also be available until December 26, 2019 via the following telephone numbers: 800.585.8367 in the U.S. and 416.621.4642 internationally using passcode 4776222.
About FactSet
FactSet (NYSE:FDS | NASDAQ: FDS) delivers superior content, analytics, and flexible technology to help more than 126,000 users see and seize opportunity sooner. We give investment professionals the edge to outperform with informed insights, workflow solutions across the portfolio lifecycle, and industry-leading support from dedicated specialists. We're proud to have been recognized with multiple awards for our analytical and data-driven solutions and repeatedly ranked as one of Fortune's 100 Best Companies to Work For® and a Best Workplace in the United Kingdom and France. Subscribe to our thought leadership blog to get fresh insight delivered daily at insight.factset.com. Learn more at www.factset.com and follow on Twitter: www.twitter.com/factset.
FactSet Media & Investor Relations Contact:Rima Hyder+1 857.265.7523 [email protected]
Source: FactSet Research Systems Inc.Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX guide: Everything you need to know about the biggest IPO in history
- Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Twitter, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share